Archived Commitments for FHI 360
Back button
Policy & Political

DateOctober 31, 2016

Updated - October 2016: FHI 360 renews its commitment to expand the evidence base for family planning programming and the translation of evidence into policy and practice. In response to a lack of knowledge about the association between hormonal contraception and HIV acquisition, FHI 360 will provide evidence to support contraceptive decision-making for women at risk of HIV infection who also wish to avoid pregnancy.  FHI 360 continues its commitment to make family planning more accessible through task-shifting, by conducting research and advocacy for policy change. FHI 360 will continue to work with government stakeholders in FP2020 countries to develop, implement, and monitor costed implementation plans for family planning. In addition, FHI 360 will advocate for the inclusion of family planning as an essential part of an integrated approach to development; when women and girls are able to plan the size of their families and time their pregnancies, we make progress on nearly every Sustainable Development Goal. 

July 11, 2012: FHI 360 will expand the evidence base for safe and effective family planning and will translate high-quality evidence into policy and practice.

Progress Reports
Submit update button
FHI360 Official Report Official report icon
DateSeptember 29, 2014
SourceFHI360
  • With support from USAID, the Bill & Melinda Gates Foundation, and other donors, FHI 360 is implementing a wide variety of projects to expand the evidence base for safe and effective family planning and translating high-quality evidence into policy and practice. For instance, a new award from the Saving Lives at Birth program will seek to synchronize immunization visits with family planning re-supply to improve immunization coverage, promote a more logical infant growth-monitoring schedule and raise contraceptive prevalence. Under the Advancing Partners & Communities (APC) Project, FHI 360 is studying self-injection of the contraceptive DMPA in a subcutaneous formulation and delivery system known as “Sayana Press” in Malawi. Also under the APC project, FHI 360 advocates for the scale-up of community-based family planning programs and supports the implementation and monitoring of national costed implementation plans (CIPs).
  • Support to the family planning strategies of local governments and for scale-up of evidence-based practices is provided by FHI 360 in multiple countries, including India (Uttar Pradesh state), where FHI 360 leads the Urban Health Initiative. FHI 360 also conducts systematic reviews on family planning for the Cochrane Collaboration, an important source of evidence for the WHO Medical Eligibility for Criteria (MEC) Guidance.
Green view updates small
Program & Service Delivery

DateOctober 31, 2016

Updated - October 2016: FHI 360 commits to progressing at least 5 new contraceptive methods through the development pipeline. FHI 360 also pledges to support the introduction of new and affordable IUDs into FP2020 target countries. Development and introduction of new contraceptive technologies, particularly long-acting methods, will not only help meet the goals of FP2020, but also maintain and expand those successes in the coming decades.

July 11, 2012: FHI 360 plans to continue its efforts to widen the array of safe, effective, acceptable and affordable contraceptives worldwide. 

Progress Reports
Submit update button
FHI360 Official Report Official report icon
DateSeptember 29, 2014
SourceFHI360
  • In addition to its work on the introduction of Sino-implant (II) and the development of longer-acting injectable contraception, FHI 360 is working with the Bill & Melinda Gates Foundation to pursue a pipeline of new contraceptive technologies for support under the Contraceptive Technology Innovation Initiative. This initiative also includes advocacy for innovative regulatory approaches to reduce the time it takes for new products to reach women and development of a new online clearinghouse that will expand global access to resources on contraceptive research, development and introduction.
  • With USAID support, FHI 360 is also working to develop a biodegradable contraceptive implant.
Green view updates small
Financial

DateOctober 31, 2012

Updated - October 2016: FHI 360 increases its financial commitment, from an original pledge of US$1 million of its own resources to a renewed pledge of US$3 million. These funds will be spent to support the development and introduction of new contraceptive technologies that will provide women in the developing world with additional high-quality, low-cost family planning options. As of the FP2020 mid-point, FHI 360 had contributed US$2.29 million of its own resources. 

July 11, 2012: FHI 360 commits to allocating US $1 million of their resources through 2020 in support of the development and introduction of new contraceptive technologies that will provide women in the developing world with additional high-quality, low-cost family planning options to fill gaps and expand choice. 

Progress Reports
Submit update button
FHI360 Official Report Official report icon
DateSeptember 29, 2014
SourceFHI360
  • From October 2012 to July 2014, FHI 360 has contributed $783,000 of its own resources in support of the development and introduction of new contraceptive technologies. This includes support for work towards the introduction of Sino-implant (II) and the development of longer-acting injectable contraception.
Green view updates small